Moderna inc er biotekselskap, grunnlagt 2010. Gikk nylig på børs 2018, ser flere har hørt om den før via, pcib, nano og targovax. Kanskje flere. Eg leser om den as we speak og kunne tenkt meg en liten krok her inne til den
Index: nasdaq
THERAPEUTIC AREAS:
- Infectious Diseases
- Immuno-Oncology
- Rare Diseases
1000 pasienter i sving prekliniske og fase 1 og et par fase 2.
Hovedstudie heter mRNA.
Litt saksing om hva Moderna selv sier:
mRNA medicines aren’t small molecules, like traditional pharmaceuticals. And they aren’t traditional biologics (recombinant proteins and monoclonal antibodies) – which were the genesis of the biotech industry. Instead, mRNA medicines are sets of instructions. And these instructions direct cells in the body to make proteins to prevent or fight disease.
Without mRNA, your genetic code would never get used by your body. Proteins would never get made. And your body wouldn’t – actually couldn’t – perform its functions. Messenger ribonucleuc acid, or mRNA for short, plays a vital role in human biology, specifically in a process known as protein synthesis. mRNA is a single-stranded molecule that carries genetic code from DNA in a cell’s nucleus to ribosomes, the cell’s protein-making machinery.
Penger:
- Cash, cash equivalents, and investments in marketable securities: $1.7 Billion (Unaudited, as of December 31, 2018)
- Total cash raised (Financing & Partners): $3.2B
- Potential $250M in Grants: Bill & Melinda Gates Foundation, BARDA & DARPA
- No Debt
(Aksjen har allerede steget over 100% fra atl, under 1 år)
Konkurransen og selskapets ledelse og samarbeider har eg desverre lite oversikt over fortsatt. Bidra gjerne
Gleder meg til å finne ut hvor denne står i det store bildet